U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   Form 10-Q/A

Mark One
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES  EXCHANGE
    ACT OF 1934

    For the quarterly period year ended September 30, 2010

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
    ACT OF 1934

    For the transition period from ____________ to _____________

                         Commission File No. 333-149857

                               GLOBAL NUTECH, INC.
                 (Name of small business issuer in its charter)

           Nevada                                                26-0338889
(State or other jurisdiction of                               (I.R.S. Employer
 incorporation or organization)                              Identification No.)

        5412 Bolsa Ave, Suite D
      Huntington Beach, California                                 92649
(Address of principal executive offices)                         (Zip Code)

                                 (714) 373-1930
                            Issuer's telephone number

      Securities registered under Section 12(b) of the Exchange Act: None

         Securities registered under Section 12(g) of the Exchange Act:

             Shares of Common Stock, $0.00001 Par Value Per Share.

Indicate by check mark  whether the issuer (1) filed all reports  required to be
filed by Section 13 or 15(d) of the  Securities  Exchange Act of 1934 during the
past 12 months (or for such shorter  period that the  registrant was required to
file such reports), and (2) has been subject to such filing requirements for the
past 90 days. Yes [X] No [ ]

Indicate  by check  mark  whether  by check  mark  whether  the  registrant  has
submitted  electronically  and posted on its corporate  Website,  if any,  every
Interactive  Data  File  required  to be  submitted  pursuant  to  Rule  405  of
Regulation S-T (Section  232.405 of this chapter) during the preceding 12 months
or for such  shorter  period  that the  registrant  was  required to submit such
files). Yes [ ] No [X]

Indicate by check mark whether the registrant is a large  accelerated  filer, an
accelerated filer, a non-accelerated  filer, or a smaller reporting company. See
the  definitions  of "large  accelerated  filer",  an  "accelerated  filer"  and
"smaller reporting company" in Rule 12b-2 of the Exchange Act."

Large accelerated filer [ ]                     Accelerated filed [ ]
Non-accelerated filer [ ]                       Smaller reporting company [X]
(Do not check if smaller reporting company)

Indicate by check mark whether the  registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act). Yes [ ] No [X]

                   APPLICABLE ONLY TO CORPORATE REGISTRANTS

Indicate the number of shares outstanding of each of the registrant's classes of
common stock,  as of the latest  practicable  date. As of November 18, 2010, the
Issuer had 131,810,000 Shares of Common Stock outstanding.

                       DOCUMENTS INCORPORATED BY REFERENCE

List hereunder the following documents if incorporated by reference and the Part
of the Form 10-Q  (e.g.  Part I, Part II,  etc.)  into  which  the  document  is
incorporated:  (1) Any  annual  report  to  security  holders;  (2) Any proxy or
information  statement;  and (3) Any prospectus  filed pursuant to Rule 424b) or
(c) under the  Securities Act of 1933.  The listed  documents  should be clearly
described for identification  purposes (e.g.,  annual report to security holders
for fiscal year ended December 24, 1980). Not applicable.
<PAGE>
                               GLOBAL NUTECH, INC.
                       (FORMERLY KNOWN AS BIO-CLEAN, INC.
                          (A DEVELOPMENT STAGE COMPANY)

                                TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements                                                   3

     Balance Sheets as of September 30, 2010 and December 31, 2009
     (Unaudited)                                                               3

     Statements of Operations for the three-month and nine-month periods
     ended September 30, 2010 and 2009, and from May 22, 2007 (Inception)
     through September 30, 2010 (Unaudited)                                    4

     Statement of Stockholders' Equity (Deficit) from May 22, 2007
     (Inception) through September 30, 2010 (unaudited)                        5

     Statements of Cash Flows as of September 30, 2010 and 2009, and from
     May 22, 2007 (Inception) through September 30, 2010 (Unaudited)           6

     Notes to the Financial Statements (Unaudited)                             7

Item 2. Management's Discussion and Analysis of Financial Condition and
        Results of Operations                                                 12

Item 3. Quantitative and Qualitative Disclosures About Market Risk            14

Item 4. Controls and Procedures                                               14

PART II - OTHER INFORMATION

Item 1.  Legal Proceedings                                                    15

Item 1A. Risks Factors                                                        15

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds          15

Item 3.  Defaults Upon Senior Securities                                      15

Item 4.  (Removed and Reserved)                                               15

Item 5.  Other Information                                                    15

Item 6.  Exhibits                                                             16

                                       2
<PAGE>
                         PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.

                              Global NuTech, Inc.
                       (Formerly Known as Bio-Clean, Inc.)
                          (A Development Stage Company)
                                 BALANCE SHEETS
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                                                   September 30,       December 31,
                                                                                       2010                2009
                                                                                    ---------           ---------
<S>                                                                                 <C>                 <C>
                                     ASSETS

Current Assets
  Cash and cash equivalents                                                         $   1,045           $      --
                                                                                    ---------           ---------
      Total Current Assets                                                              1,045                  --
                                                                                    ---------           ---------

Total Assets                                                                        $   1,045           $      --
                                                                                    =========           =========

                      LIABILITIES AND STOCKHOLDERS' DEFICIT

Current Liabilities
  Accrued expenses                                                                  $   1,500           $   1,580
  Advance from related parties                                                         83,212              29,955
                                                                                    ---------           ---------
      Total Current Liabilities                                                        84,712              31,535
                                                                                    ---------           ---------

Total Liabilities                                                                      84,712              31,535
                                                                                    ---------           ---------
Stockholders' Deficit
  Capital stock:
    Preferred Stock, $0.00001 par value, 100,000,000 shares authorized:
    Preferred Stock, Series A, $0.00001 par value, 5,000,000 shares authorized;
     0 shares issued and outstanding at September 30, 2010 and December 31, 2009,
     respectively                                                                          --                  --
    Preferred Stock, Series B, $0.00001 par value, 250,000 shares authorized;
     0 shares issued and outstanding at September 30, 2010 and December 31, 2009,
     respectively                                                                          --                  --
    Preferred Stock, Series C, $0.00001 par value, 80,000 shares authorized;
     20,000 shares issued and outstanding at September 30, 2010 and 0 shares at
     December 31, 2009, respectively                                                       --                  --
    Common Stock, $0.00001 par value, 1,400,000,000 shares authorized;
     81,810,000 and 9,090,000 shares issued and Outstanding at September 30, 2010
     and December 31, 2009, respectively                                                  819                 819
    Additional Paid in Capital                                                         65,181              53,181
    Deficit accumulated during the development stage                                 (149,667)            (85,535)
                                                                                    ---------           ---------
Total Stockholders' Deficit                                                           (83,667)            (31,535)
                                                                                    ---------           ---------

Total Liabilities and Stockholders' Deficit                                         $   1,045           $      --
                                                                                    =========           =========
</TABLE>

                 The accompanying notes are an integral part of
                     these unaudited financial statements.

                                       3
<PAGE>
                              Global NuTech, Inc.
                       (Formerly Known as Bio-Clean, Inc.)
                          (A Development Stage Company)
                            STATEMENTS OF OPERATIONS
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                                                                           Cummulative From
                                                                                                             May 22, 2007
                                           For the Three Months Ended        For The Nine Months Ended      (Inception) to
                                                  September 30,                     September 30,            September 30,
                                             2010             2009             2010             2009             2010
                                         ------------     ------------     ------------     ------------     ------------
<S>                                      <C>              <C>              <C>              <C>              <C>
Revenues                                 $         --     $         --     $         --     $         --     $         --
                                         ------------     ------------     ------------     ------------     ------------
Operating Expenses
  General and administrative                   18,701           20,868           52,132           35,503          137,667
  Compensation to officer for services         12,000               --           12,000               --           12,000
                                         ------------     ------------     ------------     ------------     ------------
      Total Operating Expenses                 30,701           20,868           64,132           35,503          149,667
                                         ------------     ------------     ------------     ------------     ------------

Net Loss                                 $    (30,701)    $    (20,868)    $    (64,132)    $    (35,503)    $   (149,667)
                                         ============     ============     ============     ============     ============

Net loss per share - basic and diluted          (0.00)           (0.00)           (0.00)           (0.00)
                                         ============     ============     ============     ============
Weighted average number of common
 shares outstanding                        81,810,000       81,810,000       81,810,000       81,810,000
                                         ============     ============     ============     ============
</TABLE>


                 The accompanying notes are an integral part of
                     these unaudited financial statements.

                                       4
<PAGE>
                               Global NuTech, Inc.
                       (Formerly Known as Bio-Clean, Inc.)
                          (A Development Stage Company)
             STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)
         For the period May 22, 2007 (Inception) to September 30, 2010
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                                                                     Accumulated
                                                                                                       Deficit
                                                               Series C                 Additional     During
                                           Common      Par    Preferred                   Paid in    Development
                                           Shares     Value     Shares     Par Value      Capital       Stage         Total
                                           ------     -----     ------     ---------      -------       -----         -----
<S>                                    <C>           <C>       <C>         <C>         <C>          <C>           <C>
Balance, May 22, 2007                           --    $  --          --      $    --     $    --      $      --     $     --
Shares issued for cash - July 2007      45,000,000      450          --           --       4,550             --        5,000
Shares issued for cash - August 2007    36,000,000      360          --           --      39,640             --       40,000
Shares issued for cash - December 2007     810,000        9          --           --       8,991             --        9,000
Net loss                                        --       --          --           --          --        (10,568)     (10,568)
                                        ----------    -----     -------      -------     -------      ---------     --------
Balance - December 31, 2007             81,810,000      819          --           --      53,181        (10,568)      43,432

Net Loss                                        --       --          --           --          --        (27,849)     (27,849)
                                        ----------    -----     -------      -------     -------      ---------     --------
Balance - December 31, 2008             81,810,000      819          --           --      53,181        (38,417)      15,583

Net Loss                                        --       --          --           --          --        (47,118)     (47,118)
                                        ----------    -----     -------      -------     -------      ---------     --------
Balance - December 31, 2009             81,810,000      819          --           --      53,181        (85,535)     (31,535)

Shares issued to officer for services           --       --      20,000           --      12,000             --       12,000
Net Loss                                        --       --          --           --          --        (64,132)     (64,132)
                                        ----------    -----     -------      -------     -------      ---------     --------

Balance - September 30, 2010            81,810,000    $ 819      20,000      $    --     $65,181      $(149,667)    $(83,667)
                                        ==========    =====     =======      =======     =======      =========     ========
</TABLE>


*    In  September  2009,  the Company  had a 9:1  forward  stock split which is
     retroactively stated.


                 The accompanying notes are an integral part of
                     these unaudited financial statements.

                                       5
<PAGE>
                               Global NuTech, Inc.
                      (Formerly Known as Bio-Clean, Inc.)
                          (A Development Stage Company)
                            STATEMENTS OF CASH FLOWS
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                                                            Cummulative From
                                                                                              May 22, 2007
                                                              For The Nine Months Ended      (Inception) to
                                                                     September 30,            September 30,
                                                                2010             2009             2010
                                                             ----------       ----------       ----------
<S>                                                          <C>              <C>              <C>
CASH FLOWS FROM OPERATING ACTIVITIES
  Net loss                                                   $  (64,132)      $  (35,503)      $ (149,667)
  Issuance of stock to officer for services                      12,000               --           12,000
  (Increase) decrease in current assets and liabilities:
    Increase in accrued expenses                                    (80)              --            1,500
    Increase in advances from related party                      53,257               --           83,212
                                                             ----------       ----------       ----------
  Net cash provided by (used in) operating activities             1,045          (35,503)         (52,955)
                                                             ----------       ----------       ----------

CASH FLOWS FROM INVESTING ACTIVITIES                                 --               --               --
                                                             ----------       ----------       ----------
CASH FLOWS FROM FINANCING ACTIVITIES
  Cash proceeds from directors as loan                               --           21,218               --
  Cash proceeds from sale of common stock                            --               --           54,000
                                                             ----------       ----------       ----------
  Net cash provided by financing activities                          --           21,218           54,000
                                                             ----------       ----------       ----------

Net increase (decrease) in cash and cash equivalents              1,045          (14,285)           1,045

Cash and cash equivalents - beginning of the period                  --           15,783               --
                                                             ----------       ----------       ----------

Cash and cash equivalents - end of the period                $    1,045       $    1,498       $    1,045
                                                             ==========       ==========       ==========

SUPPLEMENTAL CASH FLOW INFORMATION:

Cash paid for:
  Interest                                                   $       --       $       --       $       --
                                                             ----------       ----------       ----------
Income taxes                                                 $       --       $       --       $       --
                                                             ----------       ----------       ----------
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING
AND FINANCING ACTIVITIES:

Series C Preferred Shares issued to officer for services     $   12,000       $       --
                                                             ----------       ----------
</TABLE>


                 The accompanying notes are an integral part of
                     these unaudited financial statements.

                                       6
<PAGE>
                       GLOBAL NUTECH, INC. AND SUBSIDIARY
                          (A Development Stage Company)
                          Notes to Financial Statements
                               September 30, 2010
                                   (UNAUDITED)

1. ORGANIZATION AND BUSINESS OPERATIONS

Global NuTech, Inc., formerly Bio-Clean,  Inc., ("the Company") was incorporated
under the laws of the State of Nevada,  U.S. on May 22, 2007. In September 2010,
the Company  changed its name to Global  NuTech,  Inc. In  September  2009,  the
Company  effectuated a nine for one forward stock split of its common stock. The
Company  is  in  the  development  stage  as  defined  under  Development  Stage
Enterprises  (ASC 915) and its efforts are  primarily  devoted in marketing  and
distributing  beauty  products  to North  American  market.  The Company has not
generated any revenue to date and consequently its operations are subject to all
risks inherent in the establishment of a new business enterprise. For the period
from  inception,  May 22,  2007  through  September  30,  2010,  the Company has
accumulated losses of $149,667.

On September 15, 2010, the Company  acquired 100% ownership  interest in E-Clean
Acquisitions  Corporation  ("EAC"),  a Nevada  corporation  for an investment of
$100.  The purpose of  acquisition  of EAC was for this  wholly-owned  entity to
acquire other entities or enter into joint venture business partnerships.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation - Going Concern
The Company's  consolidated  financial statements are prepared using the accrual
method of  accounting  and have  been  prepared  in  accordance  with  generally
accepted  accounting  principles in the United States of America.  The financial
statements have been prepared on a going concern basis which assumes the Company
will be able to realize its assets and discharge its  liabilities  in the normal
course of business for the foreseeable  future.  The Company has incurred losses
since inception  resulting in an accumulated deficit of $149,667 as of September
30, 2010 and further losses are  anticipated in the  development of its business
raising  substantial  doubt about the  Company's  ability to continue as a going
concern.  The  ability to  continue  as a going  concern is  dependent  upon the
Company  generating  profitable  operations  in the future  and/or to obtain the
necessary  financing to meet its obligations  and repay its liabilities  arising
from  normal  business  operations  when they come due.  Management  intends  to
finance  operating  costs over the next twelve  months  with loans from  related
parties and or private placement of common stock.

Cash and Cash Equivalents
The Company  considers  all highly liquid  instruments  with a maturity of three
months or less at the time of issuance to be cash equivalents.

Use of Estimates and Assumptions
The preparation of financial  statements in conformity  with generally  accepted
accounting  principles  in the United States of America  requires  management to
make estimates and  assumptions  that affect the reported  amounts of assets and
liabilities  and disclosure of contingent  assets and liabilities at the date of
the  financial  statements  and the  reported  amounts of revenues  and expenses
during the reporting period. Actual results could differ from those estimates.

Principles of Consolidation
The  consolidated  financial  statements  include the accounts of Global NuTech,
Inc.  and its  wholly-owned  subsidiary  EClean  Acquisitions  Corporation.  All
material intercompany transactions have been eliminated in the consolidation.

Foreign Currency Translation
The  Company's  functional  currency  and its  reporting  currency is the United
States dollar.

                                       7
<PAGE>
Financial Instruments
The carrying value of the Company's  financial  instruments  approximates  their
fair value because of the short maturity of these instruments.

Stock-based Compensation
Stock-based  compensation  is accounted for at fair value in accordance with ASC
715.  To date,  the  Company  has not  adopted a stock  option  plan and has not
granted any stock options.

Income Taxes
Income  taxes are  accounted  for in  accordance  with  Statement  of  Financial
Accounting Standards No. 109 (ASC 740),  Accounting for Income Taxes. A deferred
tax  asset or  liability  is  recorded  for all  temporary  differences  between
financial and tax reporting and net operating loss carry-forwards.  Deferred tax
expense  (benefit)  results from the net change  during the year of deferred tax
assets and liabilities. Deferred tax assets are reduced by a valuation allowance
when, in the opinion of management, it is more likely than not that some portion
of all of the  deferred  tax assets will be  realized.  Deferred  tax assets and
liabilities are adjusted for the effects of changes in tax laws and rates on the
date of enactment.

Basic and Diluted Net Loss per Share
In February 1997, the FASB issued ASC 260, "Earnings Per Share", which specifies
the computation,  presentation  and disclosure  requirements for earnings (loss)
per share for entities with publicly held common stock.  ASC 260  supersedes the
provisions of APB No. 15, and requires the presentation of basic earnings (loss)
per share and  diluted  earnings  (loss) per share.  The Company has adopted the
provisions of ASC 260 effective May 22, 2007 (inception date).

Basic net loss per share  amount is  computed  by  dividing  the net loss by the
weighted average number of common shares outstanding. Diluted earnings per share
are the same as basic  earnings  per share  because  diluted  earnings per share
gives effect to all potentially  dilutive common shares  outstanding  during the
period.  Diluted EPS excludes all potentially dilutive shares since their effect
is anti-dilutive.

Fiscal Periods
The Company's fiscal year end is December 31.

Recent Accounting Pronouncements
We have reviewed all the recent  accounting  pronouncements  through ASU 2010-19
and do not believe any of these  pronouncements  will have a material  impact on
the Company.

3. INVESTMENT IN SUBSIDIARY

On September 15, 2010, the Company  acquired 100%  ownership  interest in EClean
Acquisition Corporation (EAC) from an officer of the Company for a consideration
of $100. EAC had no assets, no liabilities and accumulated loss of $100.

4. INCOME TAXES

As of September 30, 2010,  the Company had net operating  loss carry forwards of
approximately  $149,667 that may be available to reduce  future  years'  taxable
income  through 2030.  Future tax benefits  which may arise as a result of these
losses  have  not  been  recognized  in  these  financial  statements,  as their
realization  is  determined  not likely to occur.  Accordingly,  the Company has
recorded a valuation  allowance for the deferred tax asset relating to these tax
loss carry-forwards.

5. RELATED PARTY TRANSACTONS

A related party paid Company's  obligations  to vendors  amounting to $83,112 to
fund its operations as of September 30, 2010.  Advances from related  parties of
$83,212 and $29,955, are due on demand non-interest  bearing and unsecured,  and
are recorded as a current liability in the accompanying  financial statements as
of September 30, 2010 and December 31, 2009, respectively.

                                       8
<PAGE>
On September 15, 2010,  the Company  acquired 100% of ownership  interest in EAC
from an officer of the Company for $100. As of September  30, 2010,  the Company
has  recorded  $100 as payable to related  party in the  accompanying  financial
statements as of September 30, 2010.

On September  15, 2010,  the Company  issued  20,000  shares of preferred  stock
Series C,  $0.00001 par value,  valued at $12,000,  to an officer of the Company
for services performed.  The shares were valued at the fair value on the date of
issuance.  These  preferred  shares shall be entitled to convert into  2,000,000
shares of common stock  fully-paid  and  non-assessable  shares at any time. The
officer  shall have super voting rights and for voting  purposes,  each Series C
preferred share issued shall be counted as 10,000 shares of common stock per one
(1) share of Series C preferred stock.

6. COMMITMENTS AND CONTINGENCIES

A  securities  lawyer  claims  that  the  prior  control  group  of the  Company
contracted  with him on behalf of the Company to perform  securities  legal work
during the year ended December 31, 2009. The attorney claims he was paid $15,000
and is still owed $3,000. However, the attorney has not provided the new control
group with a contract  obligating  the  Company to pay.  According,  neither the
$18,000 of  expense,  nor the $3,000 in  liability,  has been  reflected  in our
financial   statements   as  of  September  30,  2010  and  December  31,  2009,
respectively.

7. STOCKHOLDERS' EQUITY

The  authorized  capital of the Company  consists of (a)  100,000,000  preferred
shares with a par value of $0.00001  per share,  of which  5,000,000  shares are
designated  as Series A preferred  shares with a par value of $0.00001,  250,000
shares are designated as Series B preferred shares with a par value of $0.00001,
and 80,000 shares are  designated as Series C preferred  shares with a par value
of $0.00001,  and (b)  1,400,000,000  common shares with a par value of $0.00001
per share.

On August 30, 2010, the Company amended its capital  structure and increased the
total  number  of   authorized   common  shares  from   100,000,000   shares  to
1,400,000,000,  with the total number of authorized  shares including common and
preferred shares to be 1,500,000,000.

Common Stock
In July 2007, the Company issued 45,000,000 shares of common stock at a price of
$0.0001 per share for total cash proceeds of $5,000. In August 2007, the Company
issued  36,000,000  shares  of common  stock at a price of $0.001  per share for
total cash  proceeds  of  $40,000.  In December  2007,  the Company  also issued
810,000  shares of common  stock at a price of $0.010  per share for total  cash
proceeds of $9,000.  During the period May 22, 2007  (inception) to December 31,
2007,  the Company sold a total of  81,810,000  shares of common stock for total
cash proceeds of $54,000.

In September  2009,  the Company  forward-split  its common  shares 9 for 1. The
above  amounts  reflect this split.  As of  September  30, 2010 and December 31,
2009, the Company had 81,810,000 shares of common stock outstanding  taking into
effect of the forward-split of its common shares 9 for 1.

On March 29,  2010,  the  Company  filed  with the Nevada  Secretary  of State a
Certificate of Designations  designating  5,000,000 shares of Series A Preferred
Stock,  $0.00001 par value per share. Each share is convertible at any time into
$1.00 of  Common  Stock of the  Company,  has a  liquidation  value of $1.00 per
share,  is not  entitled to any  dividends  and has no voting  rights other than
those prescribed the laws of the State of Nevada.

On March 29,  2010,  the  Company  filed  with the Nevada  Secretary  of State a
Certificate  of  Designations  designating  250,000 shares of Series B Preferred
Stock,  $0.00001 par value per share. Each share is convertible at any time into
$1.00 of  Common  Stock of the  Company,  has a  liquidation  value of $1.00 per
share,  is not  entitled to any  dividends  and has no voting  rights other than
those prescribed the laws of the State of Nevada.

On March 29,  2010,  the  Company  filed  with the Nevada  Secretary  of State a
Certificate  of  Designations  designating  80,000  shares of Series C Preferred
Stock,  $0.00001 par value per share.  Each share is convertible into 100 shares
of Common Stock of the  Company,  has  liquidation  rights equal to those of the

                                       9
<PAGE>
Company's  common  shares on an "as  converted"  basis,  is not  entitled to any
dividends  and has voting  rights  which  shall be counted on an "as  converted"
basis times 100.

Preferred Stock Series C
The Company's Articles of Incorporation  authorize the issuance of 80,000 shares
of $0.00001 par value Class C Preferred Stock. Under the Company's Articles, the
Board of Directors has the power,  without  further action by the holders of the
Common Stock,  to designate the relative rights and preferences of the preferred
stock, and issue the preferred stock in such one or more series as designated by
the Board of Directors.  The designation of rights and preferences could include
preferences as to liquidation,  redemption and conversion rights, voting rights,
dividends or other preferences,  any of which may be dilutive of the interest of
the holders of the Common Stock or the Preferred Stock of any other series.  The
issuance of  Preferred  Stock may have the effect of delaying  or  preventing  a
change in control of the  Company  without  further  shareholder  action and may
adversely affect the rights and powers,  including voting rights, of the holders
of Common Stock. In certain circumstances, the issuance of preferred stock could
depress the market price of the Common Stock.

The Series C preferred  shares  shall not be entitled to receipt of any dividend
and the Company's  board of directors shall not declare any dividends in respect
of the Series C preferred shares. The holders of Series C preferred shares shall
be entitled to convert  each whole  number of Series C preferred  share into 100
shares of  common  stock  issuable  upon  conversion.  The  holders  of Series C
preferred  shares and the holders of common stock shall vote together and not as
separate  classes.  For voting purposes,  each Series C preferred share shall be
counted as 10,000 shares of common stock per one (1) share of Series C preferred
stock. For the purposes of calculating the number of shares to be voted and only
such purpose, the Series C preferred shares shall be deemed not to be subject to
any  reverse  split of the  common  stock of the  Company.  In the  event of any
voluntary or involuntary liquidation,  dissolution or winding up of the Company,
the holders of Series C preferred shares shall have liquidation preference equal
to that of the  holders  of  common  stock of the  Company  on an "as  converted
basis".  All  shares of Series C  preferred  stock  shall be junior  rank to all
shares of Series A and Series B preferred  shares in respect to all  preferences
as to distributions  and payments upon the liquidation,  dissolution and winding
up of the Company.

The Company shall not effectuate any conversion of any Series C preferred  share
and no holder of any Series C  preferred  share  shall have the right to convert
and Series C  preferred  share to the extent  that after  giving  effect to such
conversion  such  person  (together  with such  person's  affiliates)  (a) would
beneficially own in excess of 4.9% of the outstanding shares of the common stock
following such conversion and (B) would have acquired, through conversion of any
Series C preferred share or otherwise (including without limitation, exercise of
any warrant),  in excess of 4.9% of the  outstanding  shares of the common stock
following such conversion.

On September  15, 2010,  the Company  issued  20,000  shares of preferred  stock
Series C,  $0.00001 par value,  valued at $12,000,  to an officer of the Company
for services performed. These preferred shares shall be entitled to convert into
2,000,000  shares of common stock  fally-paid and  non-assessable  shares at any
time. The officer shall have super voting rights and for voting  purposes,  each
Series C  preferred  share  issued  shall be counted as 10,000  shares of common
stock per one (1) share of Series C preferred stock.

8. SUBSEQUENT EVENTS

The Company has evaluated  subsequent events through November 18, 2010, the date
which the financial statements were available to be issued.

On October 8, 2010,  the  Company  amended  its  Articles  of  Incorporation  to
increase its authorized  capital for a total of One Billion Five Hundred Million
(1,500,000,000)  shares, One Billion Four Hundred Million (1,400,000,000) shares
of which are of common  stock,  $0.00001  par value per share,  and One  Hundred
Million  (100,000,000) shares of preferred stock,  $0.00001 par value, with Five
Million  (5,000,000) shares of preferred stock having previously been designated
as Series A, Two Hundred  Fifty  Thousand  (250,000)  shares of preferred  stock
having  previously  been  designated  as Series B and Eighty  Thousand  (80,000)
shares of preferred stock previously designated as Series C.

                                       10
<PAGE>
On  September  29,  2010,  EAC entered  into an  agreement  to invest in a Joint
Venture   ("JVAgreement")  with  Robert  Kavanaugh  d/b/a  Biotec  Foods,  a/k/a
Agrigenic Food Company ("Agrigenic").  Both the parties mutually agreed to amend
the closing date of the JVAgreement to October 8, 2010.  Under the  JVAgreement,
EAC will provide marketing,  distribution and sales for Agrigenic, including its
lines of dietary  supplements  for humans and animals for a period of ten years.
Pursuant to the terms of the  JVAgreement,  net  profits  will be divided 60% to
Agrigenic  and 40% to EAC.  The  Company  agreed to  invest  in the  JVAgreement
50,000,000  restricted  shares of its common  stock valued at $325,000 for EAC's
40% share of investment in the JVA. On October 8, 2010, the Company issued Fifty
Million (50,000,000)  restricted shares of its common stock for its 40% share of
investment in the Joint Venture.

                                       11
<PAGE>
ITEM 2. MANGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        OF OPERATION.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

Certain  statements  contained  in this  Quarterly  Report  on Form 10-Q for the
quarterly   period  ended   September  30,  2010   constitute   "forward-looking
statements." These statements, identified by words such as "plan," "anticipate,"
"believe,"  "estimate,"  "should," "expect," and similar expressions include our
expectations and objectives  regarding our future financial position,  operating
results and business  strategy.  These  statements  reflect the current views of
management with respect to future events and are subject to risks, uncertainties
and  other  factors  that  may  cause  our  actual   results,   performance   or
achievements,  or  industry  results,  to be  materially  different  from  those
described  in the  forward-looking  statements.  Such  risks  and  uncertainties
include those set forth under the caption "Management's  Discussion and Analysis
of Financial Condition and Results of Operation" and elsewhere in this Quarterly
Report. We advise you to carefully review the reports and documents we file from
time  to  time  with  the  Securities  and  Exchange   Commission  (the  "SEC"),
particularly our Annual Report on Form 10-K, our Quarterly  Reports on Form 10-Q
and our Current Reports on Form 8-K.

As used in this Quarterly Report,  the terms "we," "us," "our," "Global NuTech,"
and the "Company"  refer to Global  NuTech,  Inc.,  formerly known as Bio-Clean,
Inc. and Nature of Beauty, Inc., unless otherwise indicated.  All dollar amounts
in this Annual Report are expressed in U.S. dollars, unless otherwise indicated.

INTRODUCTION

The  Company was  incorporated  under the laws of the State of Nevada on May 22,
2007.  The Company is in the  development  stage as defined  under  Statement on
Financial  Accounting  Standards No. 7,  Development  Stage  Enterprises  ("SFAS
No.7"). Historically, the Company has been engaged in the business of purchasing
and  distributing  all-natural  and organic  everyday  skin care  products  from
Russia. As of the date of this Quarterly Report, we have not commenced  business
operations  and we have not  generated  any  revenues  from the  beauty  product
business.  In the later  part of 2009,  the  Company's  management  and Board of
Directors  deemed  it to be in  the  best  interests  of  the  Company  and  its
stockholders for the Company to diversify its holdings across a broader range of
industry  segments.  Doing so would provide greater growth  potential as well as
balance  cyclical  downturns.  On  October  16,  2009,  we  changed  our name to
Bio-Clean,   Inc.  and  commenced  work  on  developing   "green"  products  and
technologies,  including unique cleaning and environmental remediation products.
In September  2010,  we again changed our name to Global  NuTech,  Inc. The name
change better denotes the multi-faceted  lines of business in which we intend to
operate.  With the increase in authorized shares of our common stock will permit
us to further expand our operations through future acquisitions or joint venture
arrangements. The change of name became effective on October 8, 2010.

On  September  29,  2010,  our  wholly-owned  subsidiary,  E-Clean  Acquisitions
Corporation,  entered into a Joint Venture Agreement with Robert Kavanaugh,  dba
Agrigenic Food Company,  a biotechnology  research firm and manufacturers of the
Biotec Foods(R),  Biomed Foods(R) and Biovet  International(R)  lines of dietary
supplements.  The parties  mutually  agreed to extend the closing  date of joint
venture to October 8, 2010.  Pursuant to this agreement,  EAC will assist in the
marketing  and  distribution  of various  nutritional  and  dietary  supplements
manufactured by Agrigenic Food Company, net profits of the Joint Venture will be
divided  60% to  Agrigenic  and 40% to EAC.  We  agreed  to  invest in the Joint
Venture 50,000,000  restricted shares of our common stock valued at $325,000 for
EAC's 40% share of  investment in the Joint  Venture.  The shares were valued at
the  average  closing  price of $0.0065 on the date of  issuance.  On October 8,
2010, we issued Fifty Million (50,000,000) restricted shares of our common stock
for EAC's 40% share of investment in the Joint Venture.

RESULTS OF OPERATION

We are a  development  stage company and have not generated any revenue to date.
We have incurred  recurring  losses to date. Our financial  statements have been
prepared assuming that we will continue as a going concern and, accordingly,  do
not include adjustments relating to the recoverability and realization of assets
and classification of liabilities that might be necessary should we be unable to
continue in operation.  We expect we will require additional capital to meet our

                                       12
<PAGE>
long term operating requirements. We expect to raise additional capital through,
among other things, the sale of equity or debt securities.

The summarized  financial data is derived from and should be read in conjunction
with our unaudited  financial  statements  for the  three-month  and  nine-month
periods  ended  September  30,  2010,  including  the  notes to those  financial
statements which are included in this Quarterly Report. The following discussion
contains  forward-looking  statements  that  reflect  our plans,  estimates  and
beliefs.  Our actual results could differ materially from those discussed in the
forward-looking  statements.  Our unaudited  financial  statements are stated in
United  States  Dollars  and are  prepared  in  accordance  with  United  States
Generally Accepted Accounting Principles.

THREE-MONTH  AND NINE MONTH  PERIODS  ENDED  SEPTEMBER  30, 2010 COMPARED TO THE
THREE-MONTH AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2009.

Our net loss for the three-month and nine-month periods ended September 30, 2010
was $30,701 and $64,132 compared to a net loss of $20,868 and $35,503 during the
same comparable  periods in 2009. During the three-month and nine-month  periods
ended September 30, 2010 and 2009, we did not generate any revenue.

During the  three-month  and  nine-month  periods  ended  September 30, 2010, we
incurred general and administrative  expenses of $30,701 and $64,132 as compared
to $20,868  and $35,503  incurred  during the same  comparable  periods in 2009.
General  and  administrative   expenses  incurred  during  the  three-month  and
nine-month  periods  ended  September 30, 2010,  primarily  related to corporate
overhead,  financial  and  administrative  contracted  services  such as  legal,
professional, accounting and audit fees. On September 15, 2010, we issued 20,000
shares of preferred stock Series C, $0.00001 par value, valued at $12,000, to an
officer of the Company for services  performed.  These preferred shares shall be
entitled  to  convert  into  2,000,000  shares of common  stock  fully-paid  and
non-assessable shares at any time.

Our net loss during the  three-month  and nine-month  period ended September 30,
2010 was $30,701 or $0.00 per share and $64,132 or $0.00 per share compared to a
net loss of  $20,868  or $0.00 per share and  $35,503 or $0.00 per share for the
comparable  periods in 2009. Our cummulative  loss from May 22, 2007 (inception)
to  September  30, 2010  amounted to $149,667 or $0.00 per share.  The  weighted
average number of common shares  outstanding  was 81,810,000 for the three-month
and nine-month periods ended September 30, 2010 and 2009, respectively.

LIQUIDITY AND CAPITAL RESOURCES

NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2010

As of  September  30,  2010,  our  current  assets  were  $1,045 and our current
liabilities were $84,712,  which resulted in negative working capital of $83,667
as compared to negative working capital of $31,535 at December 31, 2009.

At September  30, 2010  current  liabilities  comprised  of accrued  expenses of
$1,500 and advances  from  related  parties of $83,212 for a total of $84,712 as
compared to $31,535 in current liabilities at December 31, 2009. The increase in
current  liabilities  during the nine-month period ended September 30, 2010 from
December 31, 2009 was primarily due to advances from a related party for payment
of corporate and administrative overheads of the Company.

Stockholders'  equity decreased from a capital deficiency of $31,535 at December
31, 2009 to capital deficiency of $83,667 at September 30, 2010.

CASH FLOWS FROM OPERATING ACTIVITIES

Net cash flows provided by operating  activities for the nine-month period ended
September 30, 2010 amounted to $1,045 due to decrease in accrued expenses of $80
and increase in advances from related parties of $53,257.

                                       13
<PAGE>
CASH FLOWS FROM INVESTING AND FINANCING ACTIVITIES

We had no cash flows from investing  activities and financing  activities during
the nine-month period ended September 30, 2010 and 2009, respectively.

We expect that working capital  requirements  will continue to be funded through
loans or the further issuances of securities.  Our working capital  requirements
are expected to increase in line with the growth of our business.

PLAN OF OPERATION AND FUNDING

Our cash reserves are not sufficient to meet our obligations for the next twelve
month period. As a result,  we will need to seek additional  funding in the near
future.  We  currently  do not have a specific  plan of how we will  obtain such
funding;  however,  we anticipate that additional funding will be in the form of
equity  financing from the sale of shares of our common stock.  We may also seek
to obtain short-term loans from our directors or unrelated parties,  although no
such arrangements have been made. At this time, we cannot provide investors with
any assurance that we will be able to obtain sufficient funding from the sale of
our common stock or through a loan from our  directors  or unrelated  parties to
meet  our  obligations  over  the  next  twelve  months.  We  do  not  have  any
arrangements in place for any future equity financing.

MATERIAL COMMITMENTS

As of the date of this Quarterly Report, we have material commitments for fiscal
year 2010. As of September  30, 2010,  we are  obligated to pay related  parties
$83,212 for  payments  made to certain  vendors and for  acquisition  for EAC on
behalf of the Company. The amounts due are non-interest bearing and payable upon
demand.

In addition,  we are  obligated to issue  50,000,000  shares of common stock for
EAC, our  wholly-owned  subsidiary's  40%  investment  in a joint  venture.  The
JVAgreement  was completed on October 8, 2010 at which time,  50,000,000  shares
were issued to the Joint Venture.

PURCHASE OF SIGNIFICANT EQUIPMENT

We do not intend to purchase any  significant  equipment  during the next twelve
months.

OFF-BALANCE SHEET ARRANGEMENTS

We do not have any off-balance  sheet  arrangements  that have or are reasonably
likely to have a current or future effect on our financial condition, changes in
financial  condition,  revenues or expenses,  results of operations,  liquidity,
capital expenditures or capital resources that are material to investors.

GOING CONCERN

The independent  auditors'  report  accompanying our December 31, 2009 financial
statements contained an explanatory paragraph expressing substantial doubt about
our ability to continue as a going concern.  The financial  statements have been
prepared "assuming that we will continue as a going concern," which contemplates
that we will realize our assets and satisfy our  liabilities  and commitments in
the ordinary course of business.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Not applicable.

                                       14
<PAGE>
ITEM 4T. CONTROLS AND PROCEDURES.

The Company, under the supervision and with the participation of its management,
including the Chief Executive Officer and the Chief Financial Officer, evaluated
the  effectiveness  of the design and  operation  of the  Company's  "disclosure
controls and  procedures"  (as defined in Rule  13a-15(e)  under the  Securities
Exchange Act of 1934,  as amended,  as of the end of the period  covered by this
report.  Based on that  evaluation,  the Chief  Executive  Officer and the Chief
Financial  Officer  concluded  that  the  Company's   disclosure   controls  and
procedures were effective as of September 30, 2010.  There has been no change in
the Company's internal control over financial reporting during the quarter ended
September 30, 2010,  that has materially  affected,  or is reasonably  likely to
materially affect, the Company's internal control over financial reporting.

                           PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

We are not a party to any material legal  proceedings and, to our knowledge,  no
such proceedings are threatened or contemplated.

ITEM 1A. RISKS FACTORS.

Not applicable.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

On August 25, 2010, the Company issued 20,000 shares of its Series C convertible
preferred stock to E. G. Marchi,  our President,  as  compensation  for services
rendered.  Each share of Series C convertible  preferred  stock may be converted
into 100 shares of common stock.  The shares of Series C  convertible  preferred
stock  were  issued  pursuant  an  exemption  provided  by  Section  4(2) of the
Securities Act of 1933.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. (REMOVED AND RESERVED).

ITEM 5. OTHER INFORMATION.

On  September  29,  2010,  our  wholly-owned  subsidiary,  E-Clean  Acquisitions
Corporation,  entered into a Joint Venture Agreement with Robert Kavanaugh,  dba
Agrigenic Food Company,  a biotechnology  research firm and manufacturers of the
Biotec Foods(R),  Biomed Foods(R) and Biovet  International(R)  lines of dietary
supplements.  The parties  mutually  agreed to extend the closing  date of joint
venture to October 8, 2010.  Pursuant to this agreement,  EAC will assist in the
marketing  and  distribution  of various  nutritional  and  dietary  supplements
manufactured by Agrigenic Food Company. Reference of this JVAgreement is made to
the Company's  Current Report on Form 8-K filed with the Securities and Exchange
Commission on October 8, 2010 for additional information on this transaction.

                                       15
<PAGE>
ITEM 6. EXHIBITS.

The following exhibits are filed as part of this Quarterly Report.

<TABLE>
<CAPTION>
Exhibit No.         Description of Exhibit                                 Location
-----------         ----------------------                                 --------
<S>            <C>                                        <C>
3.1      Articles of Incorporation                        Incorporated by reference to Exhibit 3.1
                                                          to the Company's  Registration Statement
                                                          on Form S-1 as filed with the Securities
                                                          & Exchange Commission on March 21, 2008,
                                                          as subsequently amended.

3.2      Bylaws                                           Incorporated by reference to Exhibit 3.2
                                                          to the Company's  Registration Statement
                                                          on Form S-1 as filed with the Securities
                                                          & Exchange Commission on March 21, 2008,
                                                          as subsequently amended.

3.3      Certificate of Amendment to Articles             Incorporated   by   reference   to   the
         of  Incorporation   filed  with  the             Schedule  14C -  Definitive  Information
         Nevada Nevada  Secretary of State on             Statement  filed with the  Securities  &
         October 8, 2009.                                 Exchange   Commission   on   October  on
                                                          October September 18, 2009.


3.4      Certificate of Designation of Series             Incorporated by reference to Exhibit 3.4
         A Convertible  Preferred Stock filed             of the  Company's  Annual Report on Form
         with the Nevada  Secretary  of State             10-K  filed  With  the   Securities  and
         on March 29, 2010.                               Exchange Commission on May 17, 2010.

3.5      Certificate of Designation of Series             Incorporated by reference to Exhibit 3.5
         B Convertible  Preferred Stock filed             of the  Company's  Annual Report on Form
         with the Nevada  Secretary  of State             10-K  filed  With  the   Securities  and
         on March 29, 2010.                               Exchange Commission on May 17, 2010.

3.6      Certificate of Designation of Series             Incorporated by reference to Exhibit 3.6
         C Convertible  Preferred Stock filed             of the  Company's  Annual Report on Form
         with the Nevada  Secretary  of State             10-K  filed  With  the   Securities  and
         on March 29, 2010.                               Exchange Commission on May 17, 2010.

3.7      Certificate of Amendment to Articles             Incorporated by reference to Exhibit 3.1
         of  Incorporation   filed  with  the             of the Company's  Current Report on Form
         Nevada   Secretary   of   State   on             8-K  filed  with  the   Securities   and
         September 2, 2010 (effective October             Exchange Commission on October 8, 2010.
         8, 2010).

21.1     Subsidiaries.                                    Incorporated by reference to the Form 10-Q
                                                          filed with the Securities and Exchange
                                                          Commission on November 22, 2010.

31.1     Certification of Chief Executive Officer         Included herein.
         pursuant to Section 302 of the Sarbanes-Oxley
         Act of 2002.

31.2     Certification of Chief Financial Officer         Included herein.
         pursuant to Section 302 of the Sarbanes-Oxley
         Act of 2002.

32.1     Certification of Chief Executive Officer         Included herein.
         pursuant to 18 U.S.C. Section 1350.

32.2     Certification of Chief Executive Officer         Included herein.
         pursuant to 18 U.S.C. Section 1350.
</TABLE>

                                       16
<PAGE>
                                   SIGNATURES

In  accordance  with  Section 13 or 15(d) of the Exchange  Act,  the  registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

                                        GLOBAL NUTECH, INC.


Date: January 11, 2011                 By: /s/ E. G. Marchi
                                           -------------------------------------
                                           E. G. Marchi
                                           President


                                       17